Charles J Casamento
CIK 1117167 · last filed 2026-08-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RLMD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ATHERTON, CA 94027
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ETON | Director | 71,920 | $50.44 | $3.63M | $51.4K | 11 | 2026-08-04 |
| RLMD | Director | 21,484 | $3.24 | $69.6K | -$2.11M | 32 | 2025-12-16 |
| GTBP | Director | — | $5.50 | — | $0 | 2 | 2025-09-08 |
| PaxMedica, Inc. (PXMD) Delisted | Director | 2,386 | $0.00 | $1 | $0 | 5 | 2024-03-14 |
| GridAI Technologies Corp. (FWBI) Delisted | Director | 19,937 | $2.96 | $59.0K | -$1.8K | 5 | 2024-01-04 |
| GridAI Technologies Corp. (AZRX) Delisted | Director | 22,500 | $3.45 | $77.6K | $12.7K | 15 | 2021-01-06 |
| ASTX | Director | 0 | $4.59 | $0 | -$476.8K | 10 | 2013-06-17 |
| VIVUS INC (VVUS) Delisted | Director | 2,612 | — | — | -$910.3K | 15 | 2013-04-22 |
| Astex Pharmaceuticals, Inc (SUPG) Delisted | Director | — | — | — | $0 | 6 | 2011-06-16 |
| COR | Director | 30,000 | $327.20 | $9.82M | $7.5K | 5 | 2009-08-24 |
Recent Filings · Page 4 of 15
144 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-21 | RLMD | Grant (A) | — | $0 | EDGAR |
| 2021-09-24 | RLMD | Mixed | +3,400 | -$145.4K | EDGAR |
| 2021-08-19 | RLMD | Exer (M) | +10,000 | $46.0K | EDGAR |
| 2021-07-16 | RLMD | Sell (S) | −3,300 | -$104.1K | EDGAR |
| 2021-06-22 | RLMD | — | — | $0 | EDGAR |
| 2021-06-02 | RLMD | Sell (S) | −3,000 | -$100.0K | EDGAR |
| 2021-05-05 | ETON | Grant (A) | — | $0 | EDGAR |
| 2021-05-05 | RLMD | Sell (S) | −3,000 | -$114.6K | EDGAR |
| 2021-04-05 | RLMD | Sell (S) | −3,000 | -$106.3K | EDGAR |
| 2021-03-02 | RLMD | Sell (S) | −3,000 | -$101.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.